An investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinoma

Autor: Baxter, M.A., Spender, L.C., Cairns, D., Walsh, S., Oparka, R., Porter, R.J., Bray, S., Skinner, G., King, S., Turbitt, J., Collinson, D., Miedzybrodzka, Z.H., Jellema, G., Logan, G., Kennedy, R.D., Turkington, R.C., McLean, M.H., Swinson, D., Grabsch, H.I., Lord, S., Seymour, M.J., Hall, P.S., Petty, R.D.
Zdroj: In ESMO Open May 2024 9(5)
Databáze: ScienceDirect